The Maze procedure for the treatment of atrial fibrillation: A minimally invasive approach

Journal of Cardiac Surgery

Volumn 19, Issue 3, 2004, Pages 196-200

  Ad, Niv ^a   Cox, James L ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CARDIOPULMONARY BYPASS; CONFERENCE PAPER; CRYOSURGERY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; MORBIDITY; PACEMAKER; PERIOPERATIVE PERIOD; RECURRENT DISEASE; STERNOTOMY; TECHNIQUE; TRICUSPID VALVE;

ADULT; AGED; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TRICUSPID VALVE;

EID: 2542453911     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0886-0440.2004.4036_1.x     Document Type: Conference Paper

References (16)

1. Benetti FJ, Naselli G, Wood M, et al: Direct myocardial revascularization without extracorporeal circulation. Chest 1991;100:312-216.
2. Subramanian VA, Sani G, Benetti FJ, et al: Minimally invasive coronary bypass surgery: A multi-center report of preliminary clinical experience. Circulation 1995;92(Suppl):645.
3. Stevens JH, Burdon TA, Peters WS, et al: Port-access coronary artery bypass grafting: A proposed surgical method. J Thorac Cardiovasc Surg 1996;111:567-573.
4. Schwartz DS, Ribakove G, Grossi EA, et al: Minimallly invasive mitral valve replacement: Port-access technique feasibility and myocardial function preservation. J Thorac Cardiovasc Surg 1997;113:1022-1031.
5. Cosgrove DM, Sabik JF: Minimally invasive valve surgery. Ann Thorac Surg 1996;62:596-597.
6. Cox JL: The surgical treatment of atrial fibrillation: IV. Surgical technique.J Thorac Cardiovasc Surg 1991;101:584-592.
7. Cox JL, Boineau JP, Schuessler RB, et al: Successful surgical treatment of atrial fibrillation. J AMA 1991;14:1976-1980.
8. Cox JL, Boineau JP, Schuessler RB, et al: Five-year experience with the Maze procedure for atrial fibrillation. Ann Thorac Surg 1994;56:814-824.
9. Cox JL, Jaquiss RD, Schuessler RB, et al: Modification of the Maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the Maze III procedure. J Thorac Cardiovasc Surg 1995;110(2):485-495.
10. Cox JL: The Maze III procedure for treatment of atrial fibrillation. In: Sabiston, D.C. (ed). Atlas of Cardiothoracic Surgery, W.B. Saunders Co., Philadelphia, PA, 1995;460-475.
11. Cox JL, Schuessler RB, Lappas DG, et al: An 8 1/2 year clinical experience with surgery for atrial fibrillation. Ann Surg 1996;224(3):267-275.
12. Van Dyck M, Baele P, Rennotte MT, et al: Should amiodarone be discontinued before cardiac surgery? Acta Anaesthesiol Belg 1998;39:3-10.
13. Dimopoulou I, Marathias K, Daganou M, et al: Low-dose amiodarone-related complications after cardiac operations. J Thorac Cardiovasc Surg 1997;114:31-37.
14. Kupferschmid JP, Rosengart TK, McIntosh CL, et al: Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg 1989;48:359-364.
15. Pollak PT: Clinical organ toxicity of antiarrhythmic compounds: Ocular and pulmonary manifestations. Am J Cardiol 1999;84:37R-45R.
16. Goldiner PL, Carlon GC, Cvitkovic E, et al: Factors influencing postoperative morbidity and mortality in patients treated with bleomycin. Br Med J 1978;24:1(6128):1664-1667.